AlphaTON Capital Corp. (ATON)
NASDAQ: ATON · Real-Time Price · USD
5.77
-0.48 (-7.68%)
At close: Sep 26, 2025, 4:00 PM EDT
5.60
-0.17 (-2.95%)
After-hours: Sep 26, 2025, 7:47 PM EDT
AlphaTON Capital Employees
As of March 31, 2025, AlphaTON Capital had 4 total employees, including 3 full-time and 1 part-time employees. The number of employees decreased by 3 or -42.86% compared to the previous year.
Employees
4
Change (1Y)
-3
Growth (1Y)
-42.86%
Revenue / Employee
n/a
Profits / Employee
-$1,691,750
Market Cap
13.15M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 4 | -3 | -42.86% |
| Mar 31, 2024 | 7 | 0 | - |
| Mar 31, 2023 | 7 | 1 | 16.67% |
| Mar 31, 2022 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Berkshire Hathaway | 392,400 |
| JPMorgan Chase & Co. | 317,233 |
| Wells Fargo & Company | 217,000 |
| Bank of America | 213,000 |
| HSBC Holdings | 211,304 |
| Morgan Stanley | 80,000 |
| American Express Company | 75,100 |
| The Goldman Sachs Group | 46,500 |
ATON News
- 2 days ago - AlphaTON Capital Corp Successfully Closes $71 million Financing and Completes Initial TON Token Acquisition - GlobeNewsWire
- 24 days ago - AlphaTON Capital Corp Launches TON Digital Asset Treasury Strategy for the Telegram Ecosystem - GlobeNewsWire
- 2 months ago - Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025 - GlobeNewsWire
- 3 months ago - Portage Biotech Regains Full Compliance with Nasdaq Continued Listing Requirements - GlobeNewsWire
- 3 months ago - Portage Biotech and Compedica Stock-for-Stock Exchange - GlobeNewsWire
- 5 months ago - Portage Biotech Stock Surges As It Prepares For Human Trial - Benzinga
- 5 months ago - Portage Biotech Reports Confirmatory Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7 - GlobeNewsWire
- 6 months ago - Why Is Portage Biotech Stock Skyrocketing Friday? - Benzinga